| Also known as |
Coreg |
| Blood pressure |
Lowers blood pressure |
| Chemical name |
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol |
| Dosage (medical) |
Typically 12.5 mg once daily initially, then increased to 25 mg twice daily as tolerated |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces heart rate and blood pressure, improves blood flow |
| Formula |
C24H26N2O4 |
| Half-life |
7-10 hours |
| Hepatotoxicity |
Low risk but can occur, particularly in patients with pre-existing liver conditions |
| Lab Test |
No specific lab test required regularly, liver function tests may be monitored |
| Main action |
Antihypertensive, antianginal, antiarrhythmic |
| Side effects |
Dizziness, fatigue, hypotension, diarrhea, weight gain |
| Storage conditions |
Store at controlled room temperature, away from moisture and heat |
| Strength |
12.5mg |
| Substance class |
Beta-blocker with alpha-blocking activity |
| Trade name |
Coreg |
| Use in sports |
Not typically used in sports |
| Water Retention |
Minimal |
| Manufacturer |
Johnlee Pharmaceuticals Pvt. Ltd. |
| Packing |
10 tabs/blister |
